Nucleotrace
PrivateLast Round
Grant
Oct 10, 2017
Total Funding Raised
$2,000
Company Overview
Nucleotrace operates in Frontier & Industrial Tech and is based in Melbourne. Its latest recorded funding round was a Grant round in October 2017.
Nucleotrace is a healthcare technology company that develops DNA-based tracing and identification technology for pharmaceutical supply chain monitoring and product authentication.
Sector
Frontier & Industrial Tech
Verticals
Supply Chain Tracking, Biotechnology, Pharma Supply Chain, Defense Tech
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleotrace Comparables
Compare Nucleotrace with similar companies based on industry and business-model similarity.
No comparables are published for Nucleotrace. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Nucleotrace Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nucleotrace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cicada Innovations | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2017
$2K raised from Cicada Innovations.
For institutional investors. Book with your work email.
Nucleotrace Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nucleotrace's valuation, stock price, and market status.
Is Nucleotrace a public or private company?
Nucleotrace is a private company.
What is the current stock price of Nucleotrace?
Nucleotrace is a private company, so its shares have no public market price. Caplight tracks Nucleotrace's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nucleotrace worth (valuation)?
Valuation information for Nucleotrace is not publicly available.
Can I buy Nucleotrace stock?
Nucleotrace shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nucleotrace's last funding round?
Nucleotrace's most recent funding round was Grant on October 10, 2017.
Who are the main investors in Nucleotrace?
Key investors in Nucleotrace include Cicada Innovations.
Will Nucleotrace IPO soon?
No public IPO plans have been announced for Nucleotrace.
How can I track Nucleotrace secondary market activity?
Caplight tracks bids, offers, and trades in Nucleotrace's shares on secondary markets.